Search Results - "Mörike, Klaus"

Refine Results
  1. 1

    Mechanisms and assessment of statin‐related muscular adverse effects by Moßhammer, Dirk, Schaeffeler, Elke, Schwab, Matthias, Mörike, Klaus

    Published in British journal of clinical pharmacology (01-09-2014)
    “…Statin‐associated muscular adverse effects cover a wide range of symptoms, including asymptomatic increase of creatine kinase serum activity and…”
    Get full text
    Journal Article
  2. 2

    Pharmacogenetics of antimalarial drugs: effect on metabolism and transport by Kerb, Reinhold, Dr, Fux, Richard, MD, Mörike, Klaus, MD, Kremsner, Peter G, MD, Gil, José Pedro, PhD, Gleiter, Christoph H, MD, Schwab, Matthias, MD

    Published in The Lancet infectious diseases (01-12-2009)
    “…Summary The prevention and management of malaria is primarily based on the use of drugs. Clinical trials have however revealed that between individuals there…”
    Get full text
    Journal Article
  3. 3

    Dose-Proportional Intraindividual Single- and Repeated-Dose Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor by Bethke, Thomas D., Böhmer, Gabriele M., Hermann, Robert, Hauns, Bernhard, Fux, Richard, Mörike, Klaus, David, Michael, Knoerzer, Dietrich, Wurst, Wilhelm, Gleiter, Christoph H.

    Published in Journal of clinical pharmacology (01-01-2007)
    “…The dose‐proportional, intraindividual, single‐ and repeated‐dose pharmacokinetics of roflumilast, an oral, once‐daily phosphodiesterase 4 inhibitor under…”
    Get full text
    Journal Article
  4. 4

    No Dose Adjustment on Coadministration of the PDE4 Inhibitor Roflumilast With a Weak CYP3A, CYP1A2, and CYP2C19 Inhibitor: An Investigation Using Cimetidine by Böhmer, Gabriele M., Gleiter, Christoph H., Mörike, Klaus, Nassr, Nassr, Walz, Antje, Lahu, Gezim

    Published in Journal of clinical pharmacology (01-04-2011)
    “…This nonrandomized, fixed‐sequence, 2‐period crossover study investigated potential pharmacokinetic interactions between the phosphodiesterase 4 inhibitor…”
    Get full text
    Journal Article
  5. 5

    Clinical pharmacokinetics of candesartan by GLEITER, Christoph H, MÖRIKE, Klaus E

    Published in Clinical pharmacokinetics (2002)
    “…Candesartan cilexetil is the prodrug of candesartan, an angiotensin II type 1 (AT1) receptor antagonist. Absorbed candesartan cilexetil is completely…”
    Get full text
    Journal Article
  6. 6

    Off label prescribing to children in primary care in Germany: retrospective cohort study by Bücheler, Reinhild, Schwab, Matthias, Mörike, Klaus, Kalchthaler, Bernhard, Mohr, Hartmut, Schröder, Helmut, Schwoerer, Peter, Gleiter, Christoph H

    Published in BMJ (01-06-2002)
    “…Contributors: MS, KM, and CG designed the study. PS provided access to Allgemeine Ortskrankenkasse, BadenWurttemberg, and gave information concerning drug…”
    Get full text
    Journal Article
  7. 7

    Ginger-Associated Overanticoagulation by Phenprocoumon by Kruth, Patricia, Brosi, Eberhard, Fux, Richard, Morike, Klaus, Gleiter, Christoph H

    Published in The Annals of pharmacotherapy (01-02-2004)
    “…OBJECTIVE To report a case of ginger–phenprocoumon interaction resulting in an elevated international normalized ratio (INR) and epistaxis. CASE SUMMARY A…”
    Get full text
    Journal Article
  8. 8

    Effect of High-Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction Study by Dilger, Karin, Fux, Richard, Röck, Daniel, Mörike, Klaus, Gleiter, Christop H.

    Published in Journal of clinical pharmacology (01-12-2007)
    “…Recent case reports suggest that addition of high‐dose metronidazole might be associated with elevated plasma concentrations of substrates of cytochrome P450…”
    Get full text
    Journal Article
  9. 9

    Salbutamol-Infusion erhöht Mortalität bei der Schocklunge by Mörike, Klaus

    Published in MMW Fortschritte der Medizin (01-06-2012)
    “…Beim akuten Lungen-Schädigungssyndrom scheint eine frühe intravenöse Salbutamol-Infusion die Sterblichkeit zu erhöhen. Zudem wird sie schlecht vertragen…”
    Get full text
    Journal Article
  10. 10

    Polypharmacy-an Upward Trend with Unpredictable Effects by Moßhammer, Dirk, Haumann, Hannah, Mörike, Klaus, Joos, Stefanie

    Published in Deutsches Ärzteblatt international (23-09-2016)
    “…Guideline-oriented treatments can lead to polypharmacy, i.e., the simultaneous long-term use of multiple drugs. Polypharmacy mainly affects elderly patients…”
    Get full text
    Journal Article
  11. 11

    The clinical implications of ageing for rational drug therapy by Shi, Shaojun, Mörike, Klaus, Klotz, Ulrich

    Published in European journal of clinical pharmacology (01-02-2008)
    “…Introduction The proportion of the elderly is constantly increasing and by the year 2025 20% of the population will be above 65 years of age. With advanced…”
    Get full text
    Journal Article
  12. 12

    Chronic Heart Failure by Edelmann, Frank, Knosalla, Christoph, Mörike, Klaus, Muth, Christiane, Prien, Peggy, Störk, Stefan

    Published in Deutsches Ärzteblatt international (23-02-2018)
    “…Chronic heart failure (CHF) is the most common reason for hospital admissions in Germany. For the National Disease Management Guideline (NDMG) on CHF, a…”
    Get full text
    Journal Article
  13. 13

    Dietary salt increases first-pass elimination of oral quinidine by Darbar, Dawood, Dell'Orto, Simonetta, Mörike, Klaus, Wilkinson, Grant R., Roden, Dan M.

    Published in Clinical pharmacology and therapeutics (01-03-1997)
    “…Background Some cytochrome P450 (CYP) enzymes, including CYP3A, are expressed not only in the liver but also in the intestine; the latter may therefore be an…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Problems in anticoagulation of a patient with antibiotic treatment for endocarditis: interaction of rifampicin and vitamin K antagonists by Mizera, Lars, Geisler, Tobias, Mörike, Klaus, Gawaz, Meinrad, Steeg, Martin

    Published in BMJ case reports (12-02-2018)
    “…The cytochrome P450 is a superfamily of isoenzymes that are responsible for the metabolism of many drugs. Significant changes in pharmacokinetics and drug…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Proximal femur fracture in older patients – rehabilitation and clinical outcome by Röder, Frank, Schwab, Matthias, Aleker, Thomas, Mörike, Klaus, Thon, Klaus‐Peter, Klotz, Ulrich

    Published in Age and ageing (01-01-2003)
    “…Background: hip fracture is a major cause of morbidity and mortality in older people; optimal post‐surgical treatment is a matter of controversy. Objective: to…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20